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ABSTRACT 
Ferroxidase-II was definitely identified as a lipoprotein. 
Cholesterol and phospholipids remained tightly associated with the 
ferroxidase-II protein following extensive purification. Quantitative 
analysis showed that it is a high-density lipoprotein. Thin-layer 
chromatographic analyses indicated that phosphatidylcholine accounts 
for the majority of the bound phospholipid with lysophosphatidylcholine 
and sphingomyelin accounting for the remaining.phospholipid. 
Treatment of purified ferroxidase-II with phospholipase C or A 
resulted in a loss of ferroxidase activity which paralleled the 
hydrolysis of phospholipid. Phospholipid D treatment also resulted in 
the loss of ferroxidase activity, yet the loss was not as great as 
with other phospholipases. A lipid-depleted form of ferroxidase-II 
was prepared by acetone extraction, or gel-filtration following 
treatment with phospholipase C. However, hydrolysis, not removal, of 
the lipid was sufficient for the loss of ferroxidase activity. 
Disc-gel electrophoresis and protein elution patterns from gel-
filtration columns of the native and lipid-depleted ferroxidase-II 
demonstrated that no gross structural changes occur during lipid-
depletion. The loss of copper accompanied lipid-depletion. The loss 
of copper explained the inactivation of ferroxidase-II occurring on 
hydrolysis and removal of lipids. Reconstitution studies with lipid-
depleted ferroxidase-II indicated that the changes occurring during 
hydrolvsis and removal of the lipids were not readily reversible. 
2 
LITERATURE REVIEW 
Although copper has been a useful metallic element for thousands 
of years, its presence in living matter was not discovered until about 
a century and a half ago. The amount required by an organism is 
minuscule; the adult human body, for example, contains only about 100 
milligrams of copper (1). Yet, it has been found to be involved in 
life processes to a surprising extent. Evidently copper, along with 
iron and a few other trace metals, became incorporated in living matter 
at an early stage in the evolution of life, and it has remained as a 
vital trace element ever since. 
As with most of the essential transition metals, the importance of 
copper arises from the fact that it is a required constituent of numerous 
essential proteins and enzymes. Those copper enzymes whose catalytic 
functions are well understood are listed in Table I (2). 
Copper possesses three chemical properties which account for its 
effectiveness as a biological agent (1). 
(a) Copper ions react strongly with amino acids or proteins 
and consequently form very stable chelates with 
biologically active substances. 
(b) Copper is an exceptionally effective catalytic agent. 
Its catalytic activity may be enhanced and made more 
specific when the ion is incorporated in a protein to fonn 
a copper enzyme. 
(c) Copper's ionization states have flexible properties that 
make it particularly suitable for oxidative metabolic 
functions. 
TABLE I 
IMPORTANT COPPER PROTEINS AND ENZYMES 
mol wt 
Name Where Found 103 gm Biochemical Function 
Cytochrome Most plants and 70 Terminal oxida~e 
oxidase animals 
Hemocyanin Mollusk and anthro- 450-6,680 Oxygen carrier 
pod plasma 
Ceruloplasmin Plasma of most 151 Fe(III)-transferrin 
animals formation, Copper 
transport 
Amine oxidase Most animals, etc. 225 Elastin, collagen 
, formation 
Tyrosinase Animal skin, 35 Tyrosine oxidation, 
melanoma, insects 100 skin pigment 
plants (melanin) formation 
Dopamine-13- Adrenals 290 Epinephrine biosynthesis 
hydroxylase 
Ga lactose Molds 75 Galactose oxidation 
oxidase 
Erythrocuprein Red blood cells of 34 Superoxide dismutase 
most animals 
Ascorbic acid Many plants 150 Terminal oxidase 
oxidase 
Plastocyanin Algae, green leaves 21 Photosynthesis 
and other plants 
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Interest in the biological role of copper has greatly increased as 
the recognition of its role in a number of key physiological processes 
has developed. These include its importance in elastin and collagen 
formation which prevent aneurisms, soft bones, and other defects (3,4). 
It is also an important component of cytochrome oxidase, the terminal 
oxidase of the electron transport chain of mitochondria (5). Finally, 
copper also appears to serve a vital role in the formation of hemoglobin, 
the oxygen carrying protein of blood (6,7,8). 
In 1927, Warburg and Krebs observed that mammalian blood sera 
possessed a fairly constant copper content (9). Twenty years later, 
Holmberg and Laurell demonstrated that at least 90% of normal serum 
copper was in the globulin protein fraction and that the increase in 
serum copper observed during pregnancy and infections was also associated 
with this protein fraction (10). 
In 1948, Holmberg and Laurell isolated from mammalian plasma an 
intensely blue, copper-containing protein which they named 11caeruloplasmin 11 
(11). They found that this newly identified protein had a molecular 
weight of 151,000, contained 8 copper atoms per molecule, and belonged 
to the plasma protein class of a-globulin. The a-globulin nature of 
ceruloplasmin explained Holmberg and Laurell 's earlier finding that 90% 
of the copper of serum was associated with the globulin protein fraction 
(10). 
Ceruloplasmin has been reported to have oxidase activity in vitro 
towards many substrates. Holmberg and Laurell_found oxidase activity with 
p-phenylenediamine and several other organic compounds (12). ·During his 
investigation of the effects of inorganic ions on the oxidase activity of 
purified human ceruloplasmin with N,N-dimethyl-p-phenylenediamine, 
Curzon found that the system was very sensitive to metals, both inhibition 
and activation were observed (13}. 
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The most marked activating effect was found with ferrous iron. 
Curzon and O'Reilly's experiments {14) showed that ceruloplasmin was 
able to oxidize ferrous to ferric iron and this explained the activating 
effect of iron on the ceruloplasmin catalyzed oxidation of a number of 
organic compounds. Curzon concluded that any substance which is 
oxidizable by ferric iron is potentially oxi-Oizable by the coupled 
iron-ceruloplasmin system. The effectiveness of this system and its 
ability to compete with a direct ceruloplasmin-substrate interaction 
vary widely from substrate to substrate {15). Curzon and Vallet {16) 
suggested that the conflicting results in the literature on the activity 
of ceruloplasmin against 5-hydroxytryptamine and adrenaline may to some 
extent be explicable in terms of coupled iron-ceruloplasmin oxidation 
system. 
The recognition of anemia in the copper-deficient animal was 
reported in 1928 (6). In copper-deficient pigs, it was eventually 
revealed as a severe anemia, both hypochromic and microcytic {7,18). 
Lahey, et ai. (7) compared blood analyses of five-day-old pigs fed a 
milk diet supplemented with iron and litter-mate controls on the same 
diet supplemented with both iron and copper. He observed that serum 
copper fell rapidly. ·This was followed by a decrease in serum iron, 
erythrocyte copper, and eventually by a dramatic reduction in red cell 
volume (7). In copper-deficient rats, Owen and Hazelrig observed a 
decrease in plasma ceruloplasmin and copper. The decrease in ceruolplasmin 
was followed by a slower but steady decline in liver copper and in 
hemoglobin (8). This led Cartwright, et ai. to pursue the idea of a role 
for copper in the biosynthesis of hemoglobin. This role could be effected 
at one of the three main lines of hemoglobin biosynthesis: the biosynthesis 
of protoporphyrin or heme, the utilization of iron, or the biosynthesis of 
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globin. Early hopes to find a copper-dependent step in heme biosynthesis 
were abandoned by Lee, et ai. (19). They found that as anemia developed 
in copper-deficient swine, there was a 2-3 fold increase in the activity 
of heme biosynthetic enzymes, o-aminolevulinic acid synthetase, a-keto-
glutaric acid-dependent glycine decarboxylase, and heme synthetase. 
They concluded that the anemia of copper def.iciency was not the result 
of defective heme biosynthesis and copper was not a co-factor in any of 
these reactions. There is also no evidence for any impairment 1n globin 
biosynthesis. Thus it seemed most reasonable to assume that copper is 
essential for the proper utilization of iron (19). 
While a connection between iron and copper metabolism has been 
appreciated for over 40 years, no authentic molecular mechanisms had 
been proposed until Osaki, et ai. reported on the possible significance 
of the ferroxidase activity of ceruloplasmin in nonnal human serum and 
proposed that this catalytic activity was involved in promoting the rate 
of iron saturation of transferrin in the plasma and in iron utilization 
(20,21). It is generally believed that the iron entering the blood 
stream from the intestine or liver storage sites is mostly in the ferrous 
form (22). In the plasma, Fe(II) is rapidly oxidized to Fe(III), and is 
incorporated into the specific iron-binding protein, transferrin, which 
can bind two atoms of Fe(III) per each protein molecule, forming a red 
Fe(III)-protein. When Fe(II) is added to apotransferrin, oxygen is 
required for the formation of the red complex, and the rate of color 
formation depends on the rate of Fe(II) oxidation to Fe(III) by molecular 
oxygen (22). Koechlin also mentioned that the rate of complex fonnation 
between ferrous ion and apotransferrin was enhanced by certain catalytic 
factors present in plasma (23). From Osaki and his coworkers' experiments, 
a biological role for ceruloplasmin in iron metabolism may ensue from its 
catalytic activity in converting Fe(II) to Fe(III), thereby promoting 
the rate of incorporation of Fe( III) into apotransferrin (20), as 
schematically presented below. 
2 Fe(II) ceruloplasmin Y-
reduced ~ 
ceruloplasmin 2 Fe(III) r- apotransrerr1n 
transferrin 
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The ceruloplasmin-catalyzed rate of Fe(II) oxidation under conditions 
that might be expected to prevail in human serum is 10 to 20 times faster 
than the nonenzymi c oxidation. The nonenzymi c r·ate would not account for 
the daily turnover of iron in the plasma (20). 
Any erythroid stimulation leads to a faster turnover of iron in vivo, 
and erythroid suppression has the opposite effect (24). Only the reticulo-
cytes are capable of utilizing the Fe(Ill) bound to transferrin, although 
both the reticulocytes and matured red cell can take up free Fe(III) •. 
Katz and Jandl (24) stated: 11Thus, transferrin, in some manner, directs 
the entry of iron into those cells which are still actively synthesizing 
hemoglobin and prevents its presumable needless accumulation by the 
matured cell. 11 These facts supported the generally accepted idea that 
any Fe(II) absorbed from the intestine or removed from liver storage 
sites is oxidized and incorporated into apotransferrin in the plasma, and 
transferred to the marrow. Transferrin appears to be the protein which 
exclusively supplies iron to the marrow. The availability of iron to the 
reticulocytes of the bone marrow can be rate-limiting. The rate of 
formation of Fe(lll) from Fe(ll) in plasma and of transferrin formation 
could play a significant role in the overall turnover of iron. The fact 
that·ceruolplasmin can increase this rate under physical conditions 
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suggests that thts ts a possible biological function for ceruloplasmin, 
as is schematically shown below (9,20). 
Fe(II) 
GUT 
Fe(III)-Ferritin 
-e/ ~ +e-
Fe(II)--- - --Fe( II 
\iother/ 
Fe compounds 
H20 !?-< 02 
cerulo- reduced 
plasmin cerulo-l plasmin 
Fe(Ilr:f fe(III) 
R RH po-
t rans-
ferrin 
Hemiglobin, etc. 
I 
I 
·: Other 
Fe(I I)--.!)Fe 
4\ proteins 
I 
I 
' I I 
transferri n-........... ~e( II I) 
MUCOSAL CELLS or 
LIVER STORAGE CELLS PLASMA 
RH 2 = Ascorbate 
R = Dehydroascorbate 
BONE MARROW 
Prevailing theory of iron metabolism showing the possible 
role of ceruloplasmin promoting iron utilization. 
There is now considerable evidence from both in vitro and in vivo 
systems which supports the proposal that ceruloplasmin is the key link 
between iron and copper metabolism (25,26,27,28,29). Roeser, et al. 
demonstrated that the injection of ceruloplasmin into the blood stream 
of copper-deficient pigs resulted in a rapid rise in the plasma iron 
concentration (25). This rise in plasma iron concentration was followed 
by a gradual rise in the concentration of hemoglobin of the blood stream. 
Osaki, et al. perfused livers from copper-deficient pigs with saline 
solutions containing ceruloplasmin and observed a rapid mobilization of 
stored iron from the liver into the perfusing solution (26,27). No 
mobilization of iron was observed with perfusing solution devoid of 
ceruloplasmin. 
While the name ceruloplasmin, coined by its discoverers, Holmberg 
and Laurell (11), will always retain its historical importance, Osaki, 
et al. anticipated that the name 11 Ferroxidase 11 may be more useful than 
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designating this enzyme as a sky-blue substance from plasma (20). 
One major objection was raised to the idea that ceruloplasmin is 
the key link between copper and iron metabolism. This objection arose 
from studies of iron metabolism in Hepatolenticular Degeneration, more 
conmonly referred to as Wilson's Disease (33). In this disease the serum 
is largely depleted of ceruloplasmin, and then copper diffuses into the 
tissues, where it may accumulate to a high level, particularly in the 
liver and brain. It can produce severe mental illness and death. If 
iron metabolism is dependent on ceruloplasmin, we might expect a 
disturbance in iron metabolism in Wilson's Disease. However, most 
Wilson's Disease subjects investigated were found to have low normal or 
normal levels of iron transport (30). In attempting to correlate the 
aryldiamine oxidase activity with the ferroxidase activity of sera from 
Wilson's Disease patients, it was observed that these sera had more 
ferroxidase than expected (30,31). Lee, et aZ. (32) proposed citrate 
as an alternative source of ferrous iron-oxidizing activity in low 
ceruloplasmin serum. Frieden and Osaki suggested the possibility of an 
alternative protein ferroxidase, quite different from ceruloplasmin, 
which might substitute for the normal enzyme in Wilson's Disease sera 
(30). In 1970, Topham and Frieden identified, purified, and partially 
characterized the alternative protein ferroxidase from normal human 
sera and Wilson's Disease sera {33}. They named this non-ceruloplasmin 
ferroxidase protein 11 Ferroxidase-II 11 • 
Ferroxidase-II differed from ceruloplasmin in many respects as 
illustrated in Table II{33}. 
Three of the most important differences were that Ferroxidase-II: 
{a) was yellow rather than blue as ceruloplasmin. 
{b} it was not inhibited by azide. 
{c) it exhibited no p-phenylenediamine oxidase activity. 
TABLE II 
PROPERTIES DISTINGUISHING FERROXIDASE-11 FROM CERULOPLASMIN 
PROPERTY CERULOPLASMIN FERROXIDASE-11 
Inhibition 'with 1 nt'1 > 98% None 
Azide 
Apparent Km values for 2 1 
Fe( II} 
Specific activity 30 4.9 
(A~ 60 per 10 min per 
mg of protein} 
p-Phenylenediamine oxidase Yes None 
activity 
Elution after chromatographya .2 to .3 M No NaCl required 
NaCl re-
quired 
Color of purified preparation Blue Yellow 
Molecular weight 151,000 > 800,000 
Copper content (milli- 44 12 
micromoles of copper 
per mg of protein) 
Inmunoelectrophoretic Large Small 
migration from origin 
Effect of dialysisb ~ 35% remaining 100% activity 
activity 
a Adsorption on DEAE-Sephadex; eluted with .05 M Acetate buffer, 
pH 5.5, with or without .2 to .3 M NaCl 
b Dialysis for 2 days at 4°C against .05 M acetate buffer, pH 5.5 
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The ferroxidase-11 protein in human serum, which contributes 
appreciably to the rate of Fe(lll}-transferrin formation, was shown to 
be a constituent of blood plasma Cohn fraction IV-1 (33). 
Topham and Frieden's work indicated that while the ceruloplasmin 
level of Wilson's Disease serum decreases very dramatically, ferroxidase-
II is less affected. The total ferroxidase activity of Wilson's Disease 
sera is approximately 5 ~ 10% of that of normal sera. They found only 
about 10% of the total ferroxidase activity of normal sera was necessary 
in order to observe maximum iron mobilization responses from liver (33). 
Thus, total ferroxidase of Wilson's Disease serum will be enough for 
normal or low normal iron metabolism (33,31). However, without 
ferroxidase-11 which accounts for 30% of the total ferroxidase in 
Wilson's Disease sera, this would not be possible. Ferroxidase-11 
also accounts for the fact that p-phenylenediamine oxidase activity 
(another oxidase activity of ceruloplasmin) did not correlate with 
ferroxidase activity in Wilson's Disease sera and in sera from some other 
animals (26,30,31). 
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IHTRODUCTION 
From data obtained from gel filtration and disc-gel electrophoresis 
(33), it would appear that ferroxidase-II lll.lst have a molecular weight 
between 800,000 to 2,000,000 which is lll.lch larger than the value of 
151,000 for ceruloplasmin (34). Purified ferroxidase-II was also 
subjected to irrmunoelectrophoresis. A single major precipitation arc 
was observed when cross-reacted with whole anti-human serum and stained 
with buffalo-black (33) or oil red, a stain for lipoproteins (35). The 
ferroxidase-11 protein migrated only a small distance toward the anode 
and it had a mobility similar to that of serum lipoproteins. (Cerulo-
plasmin under the same conditions, migrated lll.lch further toward the 
anode.) 
To date, no one has reported an enzymic function for _a blood lipo-
protein. The molecular weight, irrmunoelectrophoretic mobility, and 
staining characteristics of ferroxidase-II suggested that lipid components 
were tightly bound to the enzyme following extensive purification. 
Thus, this thesis sought to investigate the possible lipoprotein 
nature of ferroxidase-II. The basic approach was the following: 
(1) To establish ouantitatively that lipids were associated 
with the enzyme. 
(2) To identify the nature of the lipids associated with the 
enzyme. 
(3) To determine if these lipids were essential to the 
maintenance of the catalytic function (ferroxidase activity) 
of the enzyme. 
(4) If so, to deterr.tine how these lipids might be involved in 
the ciaintenance of catalytic activity. 
(5} To develop methods for preparing a lipid-depleted form 
of the enzyme and to attempt to reconstitute the enzyme 
by the addition of specific lipids to the lipid-depleted 
form of thP Pnzyme. 
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EXPERIMENTAL PROCEDURES 
Isolation and Purification of Ferroxidase-II from Human Plasma 
Pure ferroxidase-II was prepared from Cohn fraction IV-1 of human 
plasma basically as described by Topham and Frieden (33}. This plasma 
fraction contains ceruloplasmin (ferroxidase-1} and ferroxidase-11 as 
well as other contaminating proteins but contains only 5% of the total 
protein of blood plasma. Thus, it represents an excellent starting 
material for the purification of ferroxidase-11. Routinely, five grams 
of lyophilized Cohn IV-1 (obtained from the E. R. Squibb and Sons, Inc., 
New York, New York} was extracted with 100 ml of 0.05 M acetate buffer, 
pH 5.5, for 4 hours at 4° with gentle continuous stirring. The 
resulting extract was centrifuged at 25,000 x gravity, 4° for 30 minutes 
to remove any undissolved materials. The supernatant from this centrifu-
gation was passed through a thin layer of fine glass wool to remove the 
floating lipid layer and then dialyzed in the cold for 24 hours with 2 
liters of 0.05 M acetate buffer, pH 5.5 to remove any small molecular 
weight impurities from the Cohn IV-1 extract. The dialyzed Cohn IV-1 
extract was recentrifuged at 25,000 x gravity for 30 minutes to remove 
any material which precipitated during the dialysis. 
Ceruloplasmin {ferroxidase-I} and ferroxidase-II differ greatly in 
charge at pH 5.5. At- this pH, ceruloplasmin is highly negatively 
charged; however, ferroxidase-II bears little charge. Thus, these two 
proteins of human plasma exhibiting ferroxidase activity may be 
completely separated by chromatography on an anion exchange resin, DEAE-
sephadex A-50. The entire dialyzed extract of Cohn IV-1 (100 ml} was 
applied to a column {4 cm x 15 cm} of DEAE-sephadex A-50. The column 
was washed with 0.05 M acetate buffer, pH 5.5. Ferroxidase-I (cerulo-
plasmin} remained as a small blue band at the top of the column. 
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Ferroxidase-II was eluted from the column with.0.05 M acetate buffer, 
pH 5.5. The resulting yellowish eluant containing ferroxidase-II was 
concentrated to 30 ml by ultrafiltration in an Amicon ultrafiltration 
eel 1. 
To further purify ferroxidase-II, the concentrated solution was 
applied to a column (4.5 cm x 53 cm) of Agarose A-50 M, a molecular 
sieving material for proteins of mol. wt. 10 x 10'+ ';t 50 x 106 • Three 
bands of protein were eluted from the column with 0.05 M acetate buffer, 
pH 5.5. ·The first band was turbid and presumably contained denatured 
protein material (33). The second of these bands was clear yellow and 
possessed 90% of the ferroxidase-II activity. The third band was 
colorless and contained no ferroxidase-II activity. The second band 
was collected and concentrated by ultrafiltration to a value of 20 ml 
and passed through another Agarose A-50 M column (3 cm x 45 cm). A 
single light yellow protein band possessing ferroxidase-II activity was 
eluted from this column. 
Method of Assay of Enzymic Activity 
Ferroxidase assays were carried out spectrophotometrically measuring 
Fe3+_transferrin formation at 460 nm as previously reported (31,33). The 
basis of this assay procedure is ill~strated in the following equations: 
(1} Fe2+ + Eox -+ Fe3.+ + Ered 
(2) Fe 3+ + ApoTf + Fe 3±rf (460 nm) 
(3) Ered + ~2+ E0x + H20 
Eox =oxidized ferroxidase-II; Ered =reduced ferroxidase-11; 
~poTf = iron-free transferrin. The oxidation of iron by ferroxidase-11 
is rate-limiting (28,29}. 
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Quartz spectrophotometric cuvets, 1.5 ml in capacity and 1 cm in 
path length, contained 0.35 ml of a 0.6 M acetate buffer, pH 6.0; 0.25 ml 
of the 2% (w/v) apotransferrin solution; 0.30 ml of the 1 x 10-~ M 
ferrous anmonium sulfate solution; 0.10 ml of distilled water, and 0.10 
ml of the enzyme preparation. The time course of absorbance change at 
460 nm resulting from the formation of transferrin from apotransferrin 
and Fe(II) was recorded with a Beckman Acta-III spectrophotometer 
equipped with 0.1 absorbance scale. The specific activity was recorded 
as th~ absorbance per 10 minute per mg protein. (See ''Results") 
Quantitative Determination of Protein, Phospholipid, and Cholesterol 
Protein concentrations were determined by the method of Lowry (36). 
This method combines the use of the biuret and phenol reagents. In the 
biuret reaction, solutions containing protein are made strongly alkaline 
with sodium hydroxide and very dilute copper sulfate is added. A 
purplish to pinkish violet color is obtained. The phenol reagent 
consists of phosphomolybdic and phosphotungstic acids. The final blue 
color obtained in the Lowry method depends on a combination of the biuret 
reaction and the reduction of the phosphomolybdic-phosphotungstic reagent 
by tyrosine and tryptophan present in the protein. This method is rapid, 
sensitive (limit of detection, 5 µg/ml; 10 to 20 times more sensitive 
than simply measuring the ultraviolet absorption at 280 nm, 100 times 
more sensitive than the biuret method), and specific for protein. 
Specifically, duplicate standards of 1 ml of a bovine serum albumin 
solution (0.2 mg/ml) and a blank containing distilled water were prepared. 
~~~ 
One-tenth ml of solution of unknown protein concentration .were diluted to 
1 ml with distilled water. Five ml of Lowry B solution (2% Na 2C0 3 ; 0.1 M 
NaOH; 0.5% CuSO~; 1% sodium tartrate) were added to each tube. The tubes 
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were mixed and allowed to stand 10 minutes. To each tube was added 
0. 5 ml of phenol reagent (Phipps and Bird, RicllTlond, Virginia). Maximum 
color developed in l hour, at which time, the absorbance of each tube at 
600 nm was recorded. 
Lipid phosphorus was determined by Bartlett's method (37). This 
method is based on the detennination of inor~anic phosphate in perchloric 
acid digests of the lipid. Perchloric acid under reflux rapidly oxidizes 
lipids with quantitative release of phosphorus as inorganic phosphate. 
The inorganic phosphate is allowed to react with ammonium molybdate to 
fonn phosphomolybdic acid, which is reduced and then detennined spectro-
photometrically. As little as 0.01 micromole of phosphorus may be 
detected. Specifically, samples containing up to 0.15 micromole of 
phosphorus were digested for 20 minutes with 0.4 ml of 70 "' 72% perchloric 
acid in 18 x 150 mm test tubes. Duplicate standards of 0.3 ml of 0.5 trM 
KH2P04 (0.15 micromole of phosphorus) plus 0.4 ml of perchloric acid and 
a blank of perchloric acid alone were prepared. After digestion, the 
tubes were cooled and 2.4 ml of ammonium molybdate reagent and 2.4 ml of 
diluted (1:12, v/v) reducing agent (30 g NaHS0 3 , 6 g Na 2S0 3 , and 0.5 g 
1,2,4-aminonapthol sulfonic acid per 250 ml) were added. The samples 
were mixed and heated in a boiling water bath for 10 minutes. The tubes 
were allowed to cool and the absorbance of each tube was recorded at 
830 nm. An average molecular weight (775 g per mole) of phospholipid was 
used in the calculation of phospholipid contents. 
A simple rapid micro technique described by Zak (38) was used to 
detennine cholesterol concentrations. The technique is based on the 
precipitation of protein from the sample by the addition of an acetic 
acid solution of ferric chloride, leaving the liberated cholesterol in 
the supernatant solution. A diluted aliquot of the supernatant solution 
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is treated with concentrated sulfuric acid which yields a color that is 
stable, reproducible, and obeys Beer's law.over a wide range of analysis 
(50 ·µg to 700 µg cholesterol per ml). The colored complex and the 
mechanism of its formation are not completely understood at present. 
However, the mechanism of the reaction and formation of color does 
appear to involve oxidation and dehydration of cholesterol. Specifically, 
the following reagents were prepared: 
(a) Ferric chloride stock reagent: 840 mg of FeCl 3 • 6 H20 
was dissolved in glacial acetic acid and diluted to 100 ml 
with glacial acetic acid. 
(b) Ferric chloride precipitating reagent: Reagent (a) was 
diluted 1:10 (v/v) with glacial acetic acid. 
(c) Ferric chloride blank and diluting reagent: 8.5 ml of 
reagent (a) was diluted to 100 ml with glacial acetic acid. 
(d) Cholesterol stock standard: 100 mg of pure cholesterol was 
dissolved in glacial acetic acid and diluted to 100 ml with 
glacial acetic acid. 
(e) Cholesterol working standard: 2.5 ml of reagent (d) was 
added to 2.1 ml of reagent (a) and diluted to 25 ml with 
glacial acetic acid. (Prepared just prior to performing 
the analysis.) 
For the preparation of the standard cholesterol curve, 0, 1, 2, 
3 ml of reagent (e) were diluted to 4 ml with reagent (c) and O.l ml 
of 0.05 M acetate buffer, pH 5.5 was added to each tube. Then, from 
each tube, 3 ml of the aliquot was withdrawn and 2 ml of concentrated 
sulfuric acid was layered on the liquid surface, mixed well, and 
permitted to come to room temperature. The absorbance of each tube at 
560 nm was measured. The absorbance vs. concentration was plotted and 
19 
a linear relationship observed. For the determination of cholesterol 
content in ferroxidase-11 preparations, 0.1 ml of the sample was 
pipetted into 4 ml of the reagent (b) and mixed well. After 3 minutes, 
the mixture was filtered into a test tube. Two ml of concentrated 
sulfuric acid was mixed with a 3 ml of the aliquot of the clear yellow 
filtrate. The solution was allowed to come to room temperature. The 
absorbance was recorded at 560 nm and the cholesterol content was 
calculated from the standard curve. 
Qualitative Identification of Lipids by Thin-Layer Chromatography 
Lipid components were isolated from 2 ml of the pure ferroxidase-11 
preparations by overnight extraction with 40 ml of chloroform:methanol 
(2:1, v/v). The extracts were washed with 8 ml of distilled water by 
the procedure of Folch, et ai. {39). The lipid components were contained 
in the chloroform (lower) phase. Separation of the aqueous and chloroform 
phases during washing was greatly facilitated by the addition of a small 
quantity of solid NaCl. The chloroform phase was concentrated to a 
volume of l ml under a stream of N2 • 
Individual lipids were separated by thin-layer chromatography. Thin-
layer plates coated with silica gel H were purchased from Analtech, Co., 
Inc., Newark, Del. Plates were activated at least 1 hour at 1100 C 
before chromatography {37) •. 
{a) Identification of Individual Phospholipids: 
Solutions containing 6 mg/ml of each of the following 
standards were prepared in chloroform:methanol {2:1, v/v). 
Phosphatidylcholine {PC), lysophosphatidylcholine {LPC}, 
phosphatidylserine {PS), phosphatidylethanolamine (PE), 
sphingomyelin (SPh), cholesterol {C), and cholesterol 
acetate {CE). The standards {5 ~ 10 µl) were applied to 
the plate individually and as a mixture. Samples (50 µl) 
of the lipid extracts of ferroxidase-II were also applied 
to the plate. Chloroform:methanol:acetic acid:water 
(25:15:4:2, v/v) was used as the developing solvent. To 
detect lipid spots following development, the plates were 
allowed to dry and then placed in a tank saturated with 
iodine vapor. Lipids appeared as intense brown spots in 
the iodine vapor. 
(b) Identification of Individual Neutral Lipids: 
Solutions containing 6 mg/ml of each of the following 
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neutral lipids were prepared in chloroform:methanol (2:1, 
v/v) cholesterol (C), cholesterol acetate (CE), monoglyceride 
(monopalmitin, MG), 1,2-diglyceride (1,2-dipalmitin, 1,2-DG}, 
1,3-diglyceride (l,3-dipalmitin, 1,3-DG), triglyceride 
(tripalmitin, TG), free fatty acid (palmitic acid, FA). 
The standards (10 µl) were applied to the plate, individually 
and as a mixture. Samples of the lipid extract of ferroxidase-
II were also applied. Hexane:diethylether:acetic acid (20:80:1, 
v/v) was the developing solvent. Following development, the 
plates were allowed to dry, sprayed with 50% sulfuric acid, 
and placed in an oven at 1800 C for at least 2 hours. The 
sulfuric acid charred the lipids which then appeared as 
intense black spots. 
Treatment of Ferroxidase-II with Phospholipases 
Phospholipase A Treatments: These treatments were performed as described 
by Topham and Gaylor (40). Thirty-five µl of a phospholipase A solution 
(from Vipera russeZZi, 2 mg protein/ml, 7.7 units/mg protein; one unit 
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will hydrolyze 1 µmole of L-a-Lecithin to lysolecithin and a fatty acid 
per min., pH 6.5, at 37°), 0.5 ml of a 0.4 M CaC1 2 solution, and 2 ml of 
a purified ferroxidase-II preparation were incubated at 30° with gentle 
shaking for various time intervals. Controls containing 0.5 ml of 0.4 M 
CaCl2, 2 ml of purified ferroxidase-II, and 35 µl of 0.05 M acetate buffer, 
pH 5.5, instead of phospholipase A were incubated at 30°. The ferroxidase 
activity of each sample as well as the control and the extraction and 
separation of the individual phospholipids from each sample were carried 
out as previously described. 
Phospholipase C Treatments: These treatments were perfonned according to 
the procedure reported by Topham and Gaylor (40). Two ml of purified 
ferroxidase-II, 0.02 ml of 0.4 M CaC1 2, and 0.5 mg of phospholipase C 
(10 units/mg, l unit liberates 1.0 µmo·le of water-soluble organic 
phosphate from egg yolk lecithin per minute) were incubated at 30° with 
gentle shaking for various time intervals. Controls containing purified 
ferroxidase, CaC1 2, but no phospholipase C was incubated at 30°. The 
ferroxidase activities of the samples and of the controls were determined, 
the lipids extracted and washed, and the lipid phosphorus contents 
detennined as previously described. 
Phospholipase D Treatments: Two ml of purified enzyme, 0.02 ml of 0.4 M 
CaC1 2, and 100 µl of a pho~pholipase D solution (1 mg protein/ml) were 
incubated at 300 for various time intervals. Controls containing all 
components but 100 µl of 0.05 M acetate buffer, pH 5.5, instead of 100 µl 
phospholipase D were incubated at 300. The ferroxidase activities of the 
samples and of the controls were determined, the lipids were extracted 
and washed, and the individual phospholipids separated as previously 
described. 
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Attempt to Prepare a Lipid-Depleted Enzyme by Acetone Extraction 
A modified 'form of the procedure of Moore and Gaylor was used (41). 
Ten ml of the purified enzyme was added in dropwise manner to 30 ml of 
prechilled (-15°) acetone, stirred for 30 minutes and the temperature 
maintained at -15°. Instead of the filtration procedure suggested by 
Moore and Gaylor (41), centrifugation was used to harvest the protein 
precipitated by the acetone. The acetone-layer was decanted. A second 
30 ml ·portion of prechilled acetone was added to the ~esidue, stirred 
and centrifugated. The acetone-layer again was decanted. The resulting 
powder was dried under a gentle stream of N2 , dessicated and stored in a 
vial, and kept in the freezer until used. 
The acetone powder (3.8 mg) was dissolved in 1 ml of 0.05 M acetate 
buffer, pH 5.5, and the ferroxidase activity and the phospholipid per mg 
protein were determined. 
Attempt to Prelare Lipid-Depleted Enzyme by Phospholipase Treatment 
Followed by Ge -Filtration 
(a) Phospholipase A Treatment and Gel-Filtration: 
Four ml of the purified ferroxidase-II were treated with 
phospholipase A for 2 hours as previously described. Following 
treatment, 2 ml of the preparation was subjected to gel-
filtration on a column (0.9 x 12 cm) of Sephadex G-100. 
The protein was eluted from the Sephadex G-100 with 0.05 M 
acetate buffer, pH 5.5. The fractions from the column 
containing protein were combined. The ferroxidase activity, 
protein concentration, and phospholipid content of the 
preparation were determined as previously described, prior 
to the treatment with phospholipase A and following treatment 
with phospholipase A and gel-filtration on sephadex columns. 
Controls containing all components except phospholipase A 
were carried through the same procedure. 
(b) Phospholipase C Treatment and Gel-Filtration: 
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Thirty ml of purified ferroxidase-II, 0.3 ml of 0.4 M CaC1 2 , 
and 3.8 mg of phospholipase C were incubated for two hours 
at 30°. Following the incubation, a 20 ml sample of the 
treated material was applied to a column (3 x 45 cm) of 
Agarose A-50 M (a gel-filtration material with a greater 
capacity and larger fractionation range than the sephadex 
gels). The eluting solvent was 0.05 M acetate buffer, 
pH 5.5. Eighty 5.5 ml fractions were collected utilizing 
a Gilson Model 80 micro-fractionator. The protein 
concentration of every other fraction was determined as 
previously described. Two protein bands were eluted from 
the column. The fractions composing each of these separate 
bands were combined, concentrated by ultrafiltration, and 
the ferroxidase activity, protein concentration, phospholipid 
content and cholesterol content determined as previously 
described. A sample of purified ferroxidase-II which had 
not been treated with phospholipase C was applied to the 
same Agarose A-50 M column and subjected to gel-filtration 
in an identical manner to the treated sample. 
Disc-Gel Electrophoresis 
Disc-gel electrophoresis was performed by the simplified procedure 
described by Davis (42). Standard,uniform bore,straight glass tubes 
(120 mm x 4 mm) were filled with a 4% polyacrylamide separating gel to 
a height of 60 mm, and layered with 0.025 M Tris-glycine buffer, pH 8.8. 
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Sufficient solid sucrose was added to the ferroxidase-II preparations 
to obtain a 5% sucrose solution. Twenty-five ~l of the dense sucrose-
ferroxidase-II solution was carefully allowed to drop through the buffer 
solution to the top of the separating gel. The gels were subjected to 
5 ma per gel at pH 8.8, 0.025 M tris-glycine buffer for 35 minutes. 
After electrophoresis the gels were stained.with Coomassie Blue, a 
protein stain, as described by Chrambach, et aZ. (43). 
Copper Determination 
Copper contents of ferroxidase-II preparations were determined by 
the method of Wharton and Rader (44). This method involves the treatment 
of a protein solution with glacial acetic acid to liberate bound copper, 
reduction of the copper with mercaptoacetic acid, chelation of Cu(I) by 
bathocuproine (4,7-diphenyl-1,10-phenanthroline), precipitation of the 
protein with 95% ethanol, and removal of the precipitated Cu-free protein 
by centrifugation. The Cu(I)-bathocuproine complex is colored and the 
intensity of the color is directly proportional to the Cu concentration 
in the range of 5 to 70 nanomoles of Cu per ml. Specifically, 0.4 ml 
of the appropriate ferroxidase-II solution, 0.1 ml of a 5% (w/v) solution 
of mercaptoacetic acid, 0.5 ml of 0.1% (w/v) solution of bathocuproine 
in glacial acetic acid, o.5 ml of 95% ethanol were mixed vigorously for 
5 minutes. Blanks containing 0.4 ml of 0.05 M acetate buffer, pH 5.5 
instead of the ferroxidase-II solution were prepared in the same manner. 
A standard curve was prepared with samples containing 10, 25, 50 and 100 
nanomoles of Cu and this standard curve used for the calculation of Cu 
contents of various ferroxidase-II preparations. All samples were read 
at 479 nm. 
Reconstitution 
Attempts were made to reconstitute the enzymic activity of lipid-
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depleted ferroxidase-11 prepared by acetone extraction or phospholipase 
C treatment followed by gel-filtration. 
The lipid-depleted enzyme from acetone extraction (3.8 mg) was 
dissolved in 1 ml of 0.05 M acetate buffer, pH 5.5. To 0.35 ml of this 
solution was added 0.1 mg of phosphatidylcholine to reestablish the 
phospholipid to protein ratio present in the preparation before lipid-
depletion. The solution was incubated for 2 hours at 300. Following 
incubation, the specific activity of the solution was detennined. 
Two tenths ml of a glycerol solution of phosphatidylcholine (l.68 
mg/ml) was added to 2 ml of the lipid-depleted enzyme prepared by 
phospholipase C treatment followed by gel-filtration. This quantityof phos-
phatidylcholine was equivalent to the phospholipid present in the enzyme 
preparation prior to lipid-depletion. The resulting solution was 
incubated for 2 hours at 30°. Following incubation, the solution was 
dialyzed overnight with 0.05 M acetate buffer, pH 5.5, to remove any 
non-protein bound phosphatidylcholine. The phospholipid content, protein 
content, and specific activity of the dialyzed preparation were determined. 
A control containing 2 ml of the lipid-depleted enzyme, 0.2 ml of pure 
glycerol, but no phosphatidylcholine was incubated and dialyzed in an 
identical manner. The specjfic activity of the contrcl was detennined. 
The addition of this quantity of pure glycerol did not significantly 
affect the activity of the enzyme. 
Reconstitution was also attempted by the addition of phosphatidyl-
choline and cholesterol and by the addition of phosphatidylcholine, 
cholesterol, and copper to the lipid~depleted enzyme. Two mg of 
phosphatidylcholine and 1 mg of cholesterol were suspended in 1 ml of 
0.05 M acetate buffer, pH 5.5 by gentle homogenization. To 1 ml of the 
lipid-depleted enzyme (prepared by phospholipase C treatment and gel-
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filtration) was added 0.15 ml of the lipid suspension to reestablish 
the phospholipid and cholesterol contents present before lipid depletion. 
To another 1 ml sample of the lipid-depleted enzyme was added 0.3 ml of 
the lipid suspension to yield twice the phospholipid and cholesterol 
contents present before lipid-depletion. Both samples were incubated 
for 2 hours at 300. Following incubation, the specific activity of each 
sample was determined. 
Two mg of phosphatidylcholine and 1 mg of cholesterol were dissolved 
in glycerol. The previous experiment was repeated with the glycerol 
solution of lipid replacing the buffer suspension of lipid. 
In a third experiment, 0.15 ml and 0.3 ml of the buffer solution of 
phosphatidylcholine and cholesterol were added to 1 ml samples of the 
lipid-depleted enzyme preparation. One tenth ml of a CuS04 solution {500 
µmoles of Cu/ml) was added to the sample containing 0.15 ml of the 
buffer suspension of lipids and 1 ml of the lipid-depleted enzyme 
preparation. Two tenths ml of the CuS04 solution was added to the 
sample containing 0.3 ml of the buffer suspension of lipids and l ml of 
the lipid-depleted enzyme preparation~ These samples were incubated 
for 2 hours at 30°. Following incubation the specific activity of each 
sample was determined. 
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RESULTS 
Quantitative Determination of Lipids Bound to Ferroxidase-II 
The molecular w~ight, immunoelectrophoretic mobility, and staining 
properties reported for Ferroxidase-II by Topham and Frieden (33) 
suggested that this serum enzyme might be a lipoprotein. Most of the 
lipid bound to blood serum lipoproteins is in the form of the neutral 
lipid, cholesterol, and the polar phospholipids (46}. Thus, the phospho-
lipid and cholesterol contents of six separately purified ferroxidase-II 
preparations of high specific activity were determined. The ferroxidase-
11 preparations contained lipid both in the form of cholesterol and 
phospholipid. All six preparations had a consistent ratio of protein, 
phospholipid, and cholesterol (Table l}. The purification procedure for 
ferroxidase-II involves extensive dialysis, ion-exchange chromatography, 
ultrafiltration, and gel-filtration which should result in the loss of 
any unbound or loosely bound lipids from the ferroxidase-II preparations. 
Thus, these lipid components must be tightly associated with the purified 
enzyme. 
Qualitative Identification of Individual Phospholipid and Neutral Lipids 
Thin-layer chromatographic analyses were carried out to ascertain 
which individual phospholipids and neutral lipids were bound to 
ferroxidase-II. Phosphatidylcholine accounts for the majority of the 
bound phospholipid with small amounts of sphingomyelin and lysophospha-
tidylcholine accounting for the remaining phospholipid (Figure l}. 
Cholesterol, its esters, and other neutral lipids move with the solvent 
front in this particular developing solvent system (chloroform:methanol: 
acetic acid:water - 25:15:4:2, v/v). Therefore, in order to identify 
the neutral lipid components a second solvent system (hexane:diethyl 
ether:acetic acid= 20:80:1, v/v) was employed. Spots for cholesterol, 
TABLE 1 
Quantitative Determination of Lipids Bound to Ferroxidase-II 
' 
Enzyme Specific Activity Protein Phospholipid Cholesterol 
Preparation 
No. (A460nm/10 min/mg protein) (mg/m1) (mg/m1) (mg/m1) 
1 2.79 4.65 ± .02 0.72 ± .005 0.47 ± .06 
2 2.03 4.70 ± .05 0.60 ± .03 0.34 ± .01 
3 3.31 7.40 ± .02 0.92 ± .03 0.72 ± .03 
4 4.72 3.72 ± .02 0.43 ± .002 0.38 ± .04 
5 3.79 3.82 ± .02 0.56 ± .01 0.45 ± .03 
6 2.87 5.11 ± .03 0.68 ± .003 0.53 ± .004 
Phospho1ipid: 
Cholesterol: 
Protein 
l .5:1 :10 
1.3:0.7:10 
L3:1:10 
1.2:1 :10 
1.4:1.2:10 
1.4:1.1:10 
N 
(X) 
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FIGURE 1 
Qualitative Identification of Individual Phospholipid of Ferroxidase-11 
Thin-layer chromatographic analyses were carried out as described 
in "Experimental Procedures". The developing solvent system was 
CHC1 3 :CH30H:CH3COOH:H20 (25:15:4:2, v/v). 
1-1. Rf of standards------- C(.989); PE(.659); PS(.512); 
PC(.182); Sph(.122); LPC(.089). 
Rf of sample------- Spot #1(.989); Spot 12(.234); 
Spot #3(.124); Spot 64(.077). 
1-2. Rf of standards ------- CE(.976); C(.935); PE(.574); 
PS(.475); PC(.418); Sph(.344); LPC(.230). 
Rf of sample -------Spot 11(.984); Spot 12(.916); 
Spot #3(.457); Spot #4(.356); Spot #5(.272). 
C = Cholesterol 
CE = Cholesterol acetate 
LPC = Lysophosphatidylcholine 
PC = Phosphatidylcholine 
PE = Phosphatidylethanolamine 
PS = Phosphatidylserine 
Sph = Sphingomyelin 
f E 
f S 
1-1 
1-2 
cholesterol esters, and fatty acids were obtained with this solvent 
system (Figure 2}. 
Treatment of Ferroxidase-II with Phospholipases 
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Several enzymes attached to the inner membrane of the mitochondria 
of the cell, appear to have an absolute requirement for specific phospho-
lipids for the maintenance of enzymic activity (47). It would be quite 
interesting if the enzymic activity of ferroxidase-II, a blood serum 
1 ipoprotein, exhibited a similar requirement. Toc:Etermine whether the 
phospholipids bound to ferroxidase-II were essential for the maintenance 
of enzymic activity, purified ferroxidase-II preparations were treated 
with phospholipases, enzymes normally manufactured in the pancreas which 
catalyze the hydrolysis of phospholipids. Phospholipase A, C, and D, each 
catalyze the hydrolysis of phospholipid at a specific but different 
position as illustrated below: 
(a)· Phospholipase A hydrolysis: 
(b) 
0 
II --->-~ ~-C-0 + 
0 
II 
R-C-O-CH2 
0 
II 
R'-C-0-CH 0 I · 11 + 
CH2-0-~-0CH2CH2N{CH3)3 6-
phosphatidy1cho1ine fatty acyl group 
Phospholipase C hydrolysis: 
0 0 II II 
R-C-O-CH2 ---> R-C-O-CH2 + 
phosphatidylcholine 1,2-diglyceride 
lysophosphatidylcholine 
phosphocholine 
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FIGURE 2 
Qualitative Identification of Individual Neutral Lipids of Ferroxidase-11 
Thin-layer chromatographic analyses were carried out as described 
in "Experimental Procedures". The developing solvent system was 
hexane:diethylether:acetic acid (20:80:1, v/v). 
2-1. Rf of standards ------- TG(.932); CE(.831); FA(.729); 
l,3-DG(.712); l,2-DG(.644); C(.526); MG(.237). 
Rf of sample------- Spot #1(.864); Spot #2(.757); 
Spot #3(.7); Spot #4(.522). 
2-2. Rf of standards------- TG(.825); CE(.736); FA(.640); 
l,3-DG(.632); l,2-DG(.552); C(.474); MG(.123). 
Rf of sample------- Spot #1(.745); Spot #2(670); 
Spot #3(632); Spot #4(.482). 
C = Cholesterol 
CE = Cholesterol acetate 
1,2-DG=1,2-dipalmitin (1,2-diglyceride) 
1,3-DG = 1,3-dipalmitin (1,3-diglyceride) 
FA = Palmitic acid {free fatty acid) 
MG = Monopalmitin (monoglyceride) 
TG = Tripalmitin (triglyceride) 
2-1 
2 -2 
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(c) Phospholipase D hydrolysis: 
0 0 
R-
1
Lo-CH2 
II + 
--> R-C-0-CH2 + HOCH2CH2N(CH3 ) 3 
I~ I 
R-C-0-CH 0 
~ I 
R1-C-0-CH 0 
I II + 
CH-0-1-0-CH2CH2N(CH 3 ) 3 
I II _ 
CH2-0-P-O · 
o-
phosphatidylcholine phosphatidic acid choline 
Phospholipase C hydrolysis of phosphatidylcholine results in the 
formation of a 1 ,2-diglyceride and water-soluble phosphocholine. Thus, 
phospholipid hydrolysis could be monitored simply by following the 
disappearance of lipid bound phosphorus from chloroform:methanol extracts 
of treated ferroxidase-II preparations. Treatment of purified ferroxidase-
II with phospholipase C resulted in a progressive loss of ferroxidase 
activity which paralleled the hydrolysis of phospholipid (Figure 3-1 and 
3-2). In the first 10 minutes of treatment, the activity and phospho-
lipid content decreased dramatically; little change in activity or phospho-
lipid content was observed after 1 hour of treatment. No ferroxidase 
activity was lost from the control samples incubated without phospholipase 
C. The loss in activity and hydrolysis of phospholipid following 80 
minutes of treatment were compared for several ferroxidase-II preparations 
(Table 2). The loss of activity and hydrolysis of phospholipid were 
comparable for all four preparations examined. 
Treatment of purified ferroxidase-II with phospholipase A also 
resulted in the progressive loss of ferroxidase activity (Figure 4). 
The activity declined dramatically during the first 10 minutes of treat-
ment. No loss in ferroxidase activity was observed in the control flasks 
without phospholipase A. Phospholipase A hydrolysis of phosphatidylcholine 
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FIGURE 3-1 and 3-2 
Time Course of Loss of Ferroxidase Activity and Hydrolysis of Phospholipid 
of Ferroxidase-II with Phospholipase C 
The phospholipase C treatment of ferroxidase-II was carried out 
as described in "Experimental Procedures". Ferroxidase activities and 
phospholipid contents of ferroxidase-II were determined at several time 
intervals. 
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TABLE 2 
Comparison of Loss of Activity and Phospholipid Hydrolysis with Phospholipase C Treatment 
for Several Ferroxidase-II Preparations 
Specific Time of Activity Phospholipid 
Preparation Activity Treatment (A46onm!lO min) (mg/ml) No. (min) 
..%..To_s_s_ j_ ..HYcfr.o.l'lS. is_ 
0 1.34 
-
0.47 ± .002 
-
7 3.17 
80 0.38 71 0.14 ± .004 70 
0 1.30 
-
0.67 ± .003 
-
8 3.31 ' 
80 0.36 72 0 .15 ± .001 78 
0 o. 91 
-
0.48 ± .005 
-
9 2.79 
80 0 .17 82 0 .10 ± • 003 77 
0 0.95 
-
0.43 ± .005 
-
.10 2.03 
80 0.29 70 0.09 ± .005 80 
w 
co 
FIGURE 4 
Time Course of Loss of Ferroxidase Activity of Ferroxidase-11 with 
Phospholipase A 
The phospholipase A treatment of ferroxidase-11 was carried out 
as described ·in "Experimental Procedures". The ferroxidase activity 
of the samples was determined at several time intervals·. 
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results in the formation of lysophosphatidylcholine and a fatty acyl 
group.· Thus, phospholipid hydrolysis could not be monitored simply 
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by following the disappearance of lipid phosphorus in the chloroform: 
methanol extracts of treated samples. Phospholipid hydrolysis was 
monitored by thin-layer chromatography. Disappearance of the spot for 
phosphatidylcholine and intensification of the spot for lysophosphatidyl-
choline was observed on thin-layer chromatography of the lipid extracts 
from treated samples (Figure 5). The loss of ferroxidase activity 
following 2 hours treatment with phospholipase A was compared for 
several different ferroxidase-II preparations (Table 3). The loss in 
activity was comparable with all preparations tested. 
Treatment of purified ferroxidase-II with phospholipase D also 
resulted in the loss of activity (Figure 6). However, the extent of 
inactivation at similar time intervals was not nearly as great as 
observed in treatment with phospholipase C or A. Hydrolysis of 
phosphatidylcholine with phospholipase D results in the formation of 
phosphatidic acid and choline. Thus, phospholipid hydrolysis could 
not be monitored simply by following the disappearance of lipid phosphorus 
in the chloroform:methanol extracts of treated samples. Phospholipid 
hydrolysis was monitored by thin-layer chromatography (Figure 7). 
Little decrease in the intensity of the spot for phosphatidylcholine 
was observed suggesting that phospholipase D was not nearly as effective 
for the hydrolysis of the phospholipids bound to ferroxidase-II as 
phospholipase C or A. The extent of inactivation after 40 minutes 
treatment with phospholipase D was determined for two separate 
ferroxidase-II preparations. The loss of activity was comparable for 
the two preparations (Table 4). 
FIGURE 5 
Thin-Layer Chromatography of Phospholipids of Ferroxidase-11 Before 
and After Phospholipase A Treatment 
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The extracted samples after phospholipase A treatment were applied 
to thin-layer chromatographic plates as described in "Experimental 
Procedures". 
On the plate: 
Column #1: Mixture of standards were applied C, CE, PE, PS, PC, 
Sph, LPC. 
Column #2, #3: Extracted sample of purified ferroxidase-11. 
PC was the most intense spot. 
Column #4, #5, #6, #7, #8: Lipid extracts after 10, 20, 40, 80, 
160 minutes of phospholipase A treatment. 
Column #9: Spots of standard PC and LPC. 

Enzyme 
TABLE 3 
Comparison of Loss of Activity with Phospholipase A Treatment 
for Several Ferroxidase-II Preparations 
Specific Time of Activity 
· Preparation Activity Treatment (A46anm11 o min) . No. (hrs) 
0 1.39 
7 3.17 
2 0.48 
0 1.03 
8 3.31 
2 0.44 
0 1.03 
9 4.72 
2 0.36 
% Loss of 
Activity 
-
66 
-
58 
-
65 
.i::=. 
.p. 
FIGURE 6 
Time Course of Loss of Ferroxidase Activity with Phospholipase D 
Treatment 
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The phospholipase D treatment of ferroxidase-II was carried out 
as described in "Experimental Procedures". The ferroxidase activities 
of treated samples were determined at several time intervals. 
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FIGURE 7 
Thin-Layer Chromatographic Analysis of Phospholipids of Ferroxidase-11 
Before and After Phospholipase D Treatment 
The extracted samples after phospholipase D treatment were subjected 
to thin-layer chromatographic analysis as described in "Experimental 
Procedures". 
On the plate: 
Column #1: Mixture of standards (C, CE, PE, PS, PC, Sph, LPC 
and phosphatidic acid}. 
Column #2-#7: Extracted samples of phospholipase D treatment 
of ferroxidase-11 after 10, 20, 40, 60, 80, 160 
minutes. 
Column #8: Spot of standard phosphatidic acid. 

Enzyme 
TABLE 4 
Comparison of Loss of Activity with Phospholipase D Treatment 
for Several Ferroxidase-II Preparations 
Specific Time of Activity 
Preparation Activity Treatment 
No. (min) 
0 0.984 
8 3.31 
40 0.672 
0 1.10 
9 4.72 
40 0.55 
% Loss of 
Activity 
-
32 
-
35 
~ 
\C 
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Attempts to Prepare A Lipid-Depleted Form of Ferroxidase 
The loss of activity observed when ferroxidase-II preparations 
were treated with phospholipases, particularly phospholipase C or A, 
indicated that intact phospholipids were essential for the maintenance 
of maximum enzymic activity. It was felt that the preparation of a 
lipid-depleted form of the enzyme might provide clues regarding the 
specific role that phospholipids serve for ferroxidase-11. Furthermore, 
if a lipid-depleted form of the enzyme could be successfully prepared, 
it might be possible to reconstitute the enzymic activity by the 
addition of specific lipids and thus to establish which individual 
lipids were most essential. 
Frequently, lipids have been dissociated from lipoproteins simply 
by extraction with acetone at ice temperature (-15°). The acetone 
extraction, if successful, results in the removal of lipids and the 
precipitation of the protein without significant denaturation. Acetone 
extractions of purified ferroxidase-11 preparations resulted in the 
formation of a very finely divided precipitate which could not easily 
be isolated by filtration. The precipitate was collected by centrifu-
gation; however, the precipitate represented less than 10% by weight 
of the protein originally present in the preparation before acetone 
extraction. A portion of the powder obtained was redissolved in 0.05 M 
acetate buffer, pH 5.5, and the protein content, phospholipid content, 
and the specific activity were determined (Table 5). The phospholipid 
to protein ratio decreased dramatically indic~ting that considerable 
phospholipid had been removed during the acetone extraction; however, 
the acetone extract had little ferroxidase activity. A sample of the 
powder obtained during acetone extraction was saved for reconstitution 
experiments to be discussed later. 
TABLE 5 
Acetone Extraction of Ferroxidase-II 
Treatment Specific Activity Protein 
(A4sonm/lO min/mg protein) (mg/ml) 
None 3.77 
-
3.82 ± .02 
Redissolved 0.14 1.45 ± .05 
Acetone 
Extract 
Phospholipid 
(mg/ml) 
0.56 ± .01 
0.04 ± .001 
PhosEholiEid 
Protein 
0.15 
0.03 
<.11 
__, 
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Because of the poor yield obtained during acetone extraction, 
other methods for the preparation of a lipid-depleted form of the 
enzyme were sought. The intact phospholipids bound to ferroxidase-II 
were not removed by the gel-filtration techniques employed during the 
purification of ferroxidase-II. As previously described, the treatment 
of purified ferroxidase-II with phospholipase A or C resulted in the 
formation of hydrolysis products of the bound phospholipids. It seemed 
possible that these hydrolysis products might be more easily removed. 
from ferroxidase-II than intact phospholipids.· Thus, the preparation of 
a lipid-depleted form of the enzyme was attempted by subjecting phospho-
lipase A or C treated ferroxidase-II to gel-filtration. The loss of 
phospholipid hydrolysis products was monitored by the determination of 
total phosphorus (lipid and non-lipid phosphorus in the ferroxidase-II 
preparation before treatment and after treatment and gel-filtration) 
(See Bartlett Method; "Experimental Procedures"). It was felt that the 
phospholipase treatment and gel-filtration represented a milder procedure 
in terms of protein denaturation than subjecting the enzyme to organic 
solvent extraction. 
Ferroxidase-II preparations were treated with phospholipase A for 
2 hours and applied to a column of Sephadex G-100. A 11 ·fractions 
collected from the column containing protein were pooled. The protein 
content, phospholipid content, and specific activity of the pooled 
sample were determined. As observed in previous experiments, phospho-
lipase A treatment resulted in a dramatic decrease in the specific 
activity of the ferroxidase-II preparation, but the phospholipid:protein 
ratio following gel-filtration was only decreased by 24% (Table 6). This 
indicated that the majority of the hydrolysis products of the phospho-
1 ipids remained bound to the enzyme following gel-filtration. 
Treatment 
None 
Treatment with 
Phospholipase A 
for 2 hrs. 
followed by 
gel-filtration 
TABLE 6 
Lipid-Depletion of Ferroxidase-11 by Phospholipase A Treatment 
Followed by Gel-Filtration 
Specific Activity Protein Phospholipid PhosEholiEid (A460nm/10 min/mg protein) (mg/ml) (mg/ml) Protein 
2.53 3.76 ± .03 0.74 ± .004 0 .198 
0.51 1.57 ± • 02 0.24 ± .004 Q.153 
% Loss of 
Phospholipid 
-
24 
01 
. (Al 
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Similar experiments were performed with phospholipase C. A 
purified ferroxidase-II preparation was treated 2 hours with phospho-
1 ipase C and then subjected to gel-filtration on a column of Agarose 
A-50 M. Following gel-filtration, all column fractions containing 
protein were pooled and the protein content, phospholipid content, and 
specific activity of the pooled sample were determined. The specific 
activity of the preparation following phospholipase C treatment and gel-
filtration was drastically reduced. The phospholipid:protein ratio was 
reduced by 87% indicating that the majority of the phospholipid originally 
bound to the ferroxidase-II protein had been removed (Table 7). It was 
possible that the loss of the bound phospholipid following hydrolysis 
with phospholipase C and gel-filtration might be accompanied by a loss 
of bound cholesterol. Thus, the experiment was repeated with a second 
purified ferroxidase-II preparation and the cholesterol:protein ratio 
in addition to the phospholipid:protein ratio was determined before 
treatment and after phospholipase C treatment and gel-filtration 
(Table 8). The phospholipid:protein ratio was reduced by 83% which 
compared well to 87% observed with the first preparation. The 
cholesterol:protein ratio was also markedly reduced indicating that 
indeed bound cholesterol as well as phospholipid had been removed from 
the ferroxidase-II protein. The hydrolysis of phospholipids by phospho-
lipase C results in the formation of a 1,2-diglyceride and phosphocholine. 
Thus, a spot for 1,2-diglyceride should appear on thin-layer chromato-
graphy of a lipid extract of phospholipase C treated samples before 
gel-filtration. Following gel-filtration this spot should disappear if 
indeed the phospholipid hydrolysis products are being removed during 
the gel-filtration procedure. The appearance of a spot for 1,2-diglyceride 
was observed in lipid extracts of phospholipase C treated samples prior to 
TABLE 7 
Lipid-Depletions of Ferroxidase-II by Phospholipase C Treatment 
Followed by Gel-Filtration 
Treatment Specific Activity PhosEholiEid % Loss of 
(A460nm/10 min/mg protein) Protein Phospholipid 
Based on Protein 
None 2.97 0 .15 
-
2 hrs. with 0.09 0.020 87 
Phospholipase C 
followed by 
Agarose A-50 M 
gel-filtration 
01 
01 
Treatment 
None 
2 hrs. with 
Phospholipase C 
followed by 
Agarose A-50 M 
gel-filtration 
TABLE 8 
Lipid-Depletion of Ferroxidase-11 by Phospholipase C Treatment 
Followed by Gel-Filtration 
Specific Activity 
{A460nm/10 min/mg protein) 
Phos_Q.holi~id/Protein Chol esterol_LProtein 
ratio i Loss ratio ~ Loss 
1.73 0.12 
-
0.08 
-
0 0.02 83 0.03 63 
01 
O"I 
gel-filtration. This spot was not observed with lipid-extracts of 
phospholipase C treated samples following gel-filtration (Figure 8). 
Investigations Concerning Possible Structural Changes and Loss of 
Copper During Lipid-Depletion . 
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The treatment of ferroxidase-II with phospholipase C followed by 
gel-filtration provided a method for the preparation of a lipid-depleted 
form of the enzyme in high yield. The removal of bound lipid could 
possibly alter the structure of ferroxiqase-II and this alteration in 
structure could result in the loss of activity~ To determine if any 
large change in the structure of ferroxidase-II had occurred during 
lipid depletion, the elution patterns of the native and lipid-depleted 
ferroxidase-II protein from an Agarose A-50 M column were compared. 
The elution patterns for native and lipid-depleted ferroxidase-II were 
extremely similar (Figure 9). However, with the lipid-depleted 
ferroxidase-II preparation a very small turbid band of protein (< 15% 
of the total protein) was eluted prior to the major protein band. This 
minor band could represent a small amount of denatured protein which 
may have been formed during the gel-filtration or incubation procedures. 
The major protein band obtained with the lipid-depleted sample had an 
elution volume identical to that of the native enzyme.. This would 
indicate that no gross changes in the three-dimensional shape of the 
protein occurred during the lipid-depletion procedure. Native and 
lipid-depleted ferroxidase-II were also subjected to disc-gel electro-
phoresis (a technique which separates proteins in the basis of size, 
shape, and charge simultaneously). The electrophoretic mobilities of 
the native and lipid-depleted enzyme were identical (Figure 10). The 
electrophoretic results also indicated that no gross chang~ in the three-
dimensional shaoe had occurred during the lipid-depletion procedure. 
FIGURE 8 
Neutral Lipid Components of Ferroxidase-II Before and After Lipid-
Depletion by Phospholipase C Treatment and Gel-Filtration 
58 
Thin-layer chromatographic analyses were carried out as described 
in "Experimental Procedures". The developing solvent system was 
hexane:diethylether:acetic acid (20:80:1, v/v). 
8-1. Rf's of standards ------- TG(.932); CE(.831); FA(.729); 
l,3-DG(.712); l,2-DG(.644); C(.526); MG(.237) 
Rf's of extracted ferroxidase-11 ~------Spot #1(.894); 
Spot #2(.787); Spot #3(7); Spot #4(.532). 
Rf's of extracted sample after phospholipase C treatment 
followed by gel-filtration------- Spot #1(.816); 
Spot #2(.702); Spot #3(.64); Spot #4(.517). 
8-2. Rf's of standards ------- TG(.825); CE(.736); FA(.64); 
l,3-DG(.632); l,2-DG(.552); C(.474); MG(.123). 
Rf's of extracted ferroxidase-11 (enzyme) -------
Spot #1(.799); Spot #2(.745); Spot #3(.632); Spot #4 
(.482). 
Rf's of extracted sample of ferroxidase-II after 
phospholipase C treatment (ECT) -------Spot #1(.702); 
Spot #2(.526); Spot #3(.456). 
Rf's of extracted sample of ferroxidase-II after 
phospholipase C treatment followed by gel-filtration 
(1) Band a (ECTA-50 Ba) -------Spot #1(.768) 
(2) Band b (ECTA-50 Bb) -------Spot #1(.797); 
Spot #2(.655}; Spot #3(.584); Spot #4(.469). 
8-1 
8-2 
FIGURE 9 
Comparison of Protein Elution Patterns for Native and Lipid-Depleted 
Ferroxidase-II 
The protein elution patterns of gel-filtration of native and 
lipid-depleted ferroxidase-II were determined as described in 
"Experimental Procedures". 
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FIGURE 10 
Comparison of Electrophoretic Mobilities of the Native and Lipid-Depleted 
Enzyme Preparations 
Disc-gel electrophoresis was performed as described in "Experimental 
Procedures". The electrophoretic mobilities of native and lipid-depleted 
ferroxidase-II were compared. 
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Copper remains tightly associated with ferroxidase-II following 
purification (33) and this copper associated with ferroxidase-II has 
been shown to be essential for its ferroxidase activity (48}. The 
removal of lipid components from ferroxidase-II might in some manner 
effect the afinity of the enzyme for copper. Thus, the copper content, 
phospholipid content, cholesterol content, and specific activity before 
and after lipid-depletion were compared for a purified ferroxidase-II 
preparation. As expected from previous experiments, a dramatic loss 
in the phospholipid and cholesterol bound to the ferroxidase-II was 
observed following phospholipase C treatment and gel-filtration. A 
dramatic loss of bound copper accompanied the loss of the lipid 
components (Table 9). 
Reconstitution Attempts 
A dramatic decrease in the specific activity of purified 
ferroxidase~II preparations was observed when bound phospholipids were 
hydrolyzed by phospholipase treatment or removed by acetone extraction 
or phospholipase C treatment followed by gel-filtration. This indicated 
that the lipid must be essential for the maintenance of the catalytic 
activity of ferroxidase-II. Reconstitution experiments were performed 
to attempt to restore the activity of the lipid-depleted enzyme by the 
addition of specific lipids or specific lipids and copper. 
The addition of phosphatidylcholine to the acetone extracted enzyme 
did not result in a significant reconstitution of ferroxidase activity 
(Table 10). The addition of phosphatidylcholine to ferroxidase-II 
depleted of lipid by phospholipase C and gel-filtration also did not 
result in a significant reconstitution of the ferroxidase activity 
(Table 11). Furthermore, little phosphatidylcholine appeared to bind 
the lipid-depleted enzyme. 
Treatment 
None 
Agarose A-50 
M Gel-
filtration 
after phos-
pholipase 
C treat-
·ment 
TABLE 9 
Lipid and Copper Depletion of Ferroxidase-II by Phospholipase C Treatment 
Followed by Gel-Filtration 
Specific Activity PhosEholiEid Cholesterol Copper Content 
(A460nm110 min/mg protein) Protein Protein (nanomoles/mg protein} 
2.59 0.15 0.09 10.29 
B 
A 
N 1 0 0 0 0 
D 
B 
A 2 0.08 0.05 0.03 0.54 N 
D 
en 
U1 
Treatment 
None 
Following 
acetone 
extraction 
Reconstitution 
after acetone 
extraction 
TABLE 10 
Addition of Phosphatidylcholine to Acetone-Extracted Ferroxidase-II 
Activity Protein Specific Activity Recovery of 
(A460nm/10 min) (mg/ml) (A460nm/10 min/mg protein} Specific Activity 
1.42 3.82 ± .02 3.77 -
0.02 1.45 ± .01 0.14 -
0.05 l .45 ± • 01 0.34 . 9.0% 
°' 
°' 
TABLE 11 
Addition of Phosphatidylcholine to Lipid-Depleted Ferroxidase-II 
Treatment PhosEholiEid Specific Activity Percentage of 
Protein {A46anm/10 min/mg protein) the original S_Q_eci fi c Acti.vi tr 
None 0.17 2.36 100% 
2 hrs. with 0.07 0.25 10.6% 
Phospholipase C 
followed by 
gel-filtration 
2 hrs. of o. 10 0.08 3.4% 
incubation of 
lipid-depleted 
enzyme with 
phosphatidyl-
choline in 
glycerol 
solution 
°' ...... 
The treatment of ferroxidase-11 with phospholipase C followed by 
gel-filtration resulted in the loss of cholesterol and copper as well 
as phospholipid. Thus, it was felt that better reconstitution might 
be achieved by including cholesterol and copper in the reconstitution 
medium. However, neither the addition of cholesterol nor copper 
improved the recovery of ferroxidase activity (Table 12). These· 
results suggested that the removal of the lipids from ferroxidase-II 
promoted a change in the enzyme which prevented the rebinding of 
exogeneously added lipids or copper. 
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TABLE 12 
Addition of Phosphatidylcholine, Cholesterol, and Copper to Lipid-~epleted Ferroxidase-II 
Treatment Specific Activity Percentage of the 
(A460nm/10 min/mg protein) Original 
S_2.ecific Activity_ 
None 2.59 100% 
2 hrs. with Phospholipase C Treatment 0.08 3. 1% 
followed by Agarose A-50 M gel-filtration 
2 hrs. incubation of lipid Adding back to the 
and copper depleted enzyme original ratio of 
with acetate buffer sus- phospholipid, and 0.00 -
pension of phosphatidyl- cholesterol to 
choline and cholesterol - protein 
Adding back twice 
the original ratio 0 .11 4.2% 
2 hrs. incubation of lipid Adding back to the 
and copper depleted enzyme original ratio of 
with glycerol solution of phospholipid, and 0.00 
-
phosphatidylcholine and cholesterol to 
cholesterol m-otein 
Adding back twice 
the original ratio 0.11 4.2% 
2 hrs. incubation of lipid Adding back to the 
and copper depleted enzyme original ratio of 
with acetate buffer sus- phospholipid, 0.00 
-
pension of phosphatidyl- cholesterol, and 
choline, cholesterol, and cop_p_er to protein 
copper Adding back twice 
the original ratio 0.15 5.8% 
O'I 
l.O 
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DISCUSS IO~ 
It was recognized many years ago that there was a close relation-
ship between lipids and proteins in many natural sources. In fact, many 
proteins appear to complex lipid co:r.ponents very strongly. As data 
accumulated on the chemical nature of these cor.:plexes, now tenned 
lipoproteins, it was evident that the linkage was not of a covalent but 
rather of an associated type. Many type associations, based on the 
different polarity regions of lipids and proteins arc possible. Hon-
polar groups in the side chains of the amino acids of the protein r.~y 
fonn hydrophobic bonds with the long saturated or unsaturated carbon 
chains of the triglyceride, fatty acids, phospholipfds or sterols. 
Polar groups in the amino acid side chains r..ay also hydrogen bond groups 
of similar polarity, particularly the hydroxy functional groups present 
in sterols and phospholipids. The negatively charged phosphate groups 
present in the phospholipid may also form strong ionic bonds with 
positively charged amino groups present in th~ side chain of tha basic 
amino acids of the protein. 
To date, the COlilplcte detailed three df~nsional structure of a 
single lipoprotcin has not yet been detennined. However, the lipoproteins 
from blood have received considerable attention. These studies have shown 
that there are several different types of lipoproteins and that these r~y 
be categorized conveniently on the basis of their density (46). The law-
density lipoproteins contain approxinately eo: by weight of lipid and 
20: by weight of protein. The low-density lipoproteins contain large 
quantities of bound triglycerides, cholesterol (or its esters), but ~all 
quantities of bound phospholipids. In contrast, the high-density lipo-
proteins contain greater than so: by weight of protein and less than so: 
bv weiqht of lipid. The high-density lipoprotcins contain large 
quantities of bound phospholipid and cholesterol (or its esters) but 
very small quantities of bound triglycerides. 
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Topham and Frieden's work (33) indicated that ferroxidase-II .could 
possibly be a serum lipoprotein. The present study definitely establishes 
the lipoprotein nature of ferroxidase-II. Ferroxidase-II was found to be 
approximately 80% by weight of protein and 20% by weight of lipid. 
Phospholipid and cholesterol (or its esters) accounted for most of the 
lipid of ferroxidase-II. Phosphatidylcholine constituted the majority 
of the phospholipid and lysophosphatidylcholine and sphingomyelin 
accounted for the remaining phospholipid. The relative quantities of 
lipids and protein and the predominance of phospholipids and cholesterol 
would place ferroxidase-II in the high-density class of blood serum 
l i poprote ins. 
The lipoprotein nature of ferroxidase-II is quite interesting from 
another point of view. It represents the discovery of the first example 
of a serum lipoprotein that possesses an enzymic activity. Furthermore, 
intact phospholipids appear to be essential for maintenance of enzymic 
activity. Hydrolysis of the phospholipid with either phospholipase A 
or C resulted in a loss of activity which paralleled the hydrolysis of 
phospholipid. Treatment with phospholipase D resulted irt some loss of 
activity but the loss was not nearly as.complete as observed with 
phospholipase A or C. The larger size.of phospholipase D may prevent 
it from coming in contact with the majority of the phospholipid bound to 
ferroxidase-II and thus account for the much lower degree of inactivation 
and phospholipid hydrolysis. Phospholipases A and C hydrolyze phospha-
tidylcholine at different but at specific positions. The nature of the 
hydrolysis products is also quite different. Hydrolysis with phospho-
1 ipase A results in the loss ·of a non-polar fatty acyl group at the 2 
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position with the formation of lysophosphatidylcholine (See 11Results 11 ). 
In contrast, hydrolysis with phospholipase C results in the loss of 
phosphocholine, the polar head group, with the formation of a 1,2-
diglyceride. The hydrolysis of either the non-polar tail or the polar 
head group was sufficient for the loss of activity which would suggest 
that no single structural feature of the pho5pholipid is solely important 
for the maintenance of enzymic activity. Rather, it would appear that 
both polar and non-polar groups may be involved. 
The lipid components could be removed from ferroxidase-II by acetone 
extraction or phospholipase C treatment followed by gel-filtration. 
However, hydrolysis not removal of the phospholipid components was 
sufficient for loss of ferroxidase activity. 
The loss of ferroxidase activity upon hydrolysis of the phospholipid 
associated with ferroxidase-II could be explained in several ways. The 
phospholipid could be important for the maintenance of the native structure 
of ferroxidase-II and hydrolysis of the bound phospholipid could result 
in an alteration in the three dimensional structures which would result 
in inactivation of ferroxidase-II. However, the elution pattern of 
native and lipid-depleted ferroxidase-II from gel-filtration columns 
were very similar. The mobilities of the nature and lipid-depleted 
ferroxidase-II upon disc-gel electrophoresis, a technique for the 
simultaneous separation of proteins on' the basis of size and charge, were 
also similar. These results would suggest that no gross changes in the 
three dimensional shape of ferroxidase-II occurred following hydrolysis 
and removal of the bound phospholipid. However, small subtle changes in 
the structure of ferroxidase-II following hydrolysis and removal of lipids 
can not be ruled out. To detect small structural changes would require 
the crystallization of both native and lipid-depleted ferroxidase-II 
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and x-ray crystallographic analyses of both. The crystallization of 
ferroxidase-II, in fact .of any lipoprotein, has not yet been achieved. 
Even if crystalline ferroxidase-II were available, its very large. 
molecular weight would make an x-ray analyses quite complex. Furthermore, 
considerable uncertainty concerning the fair comparison of crystalline 
and solution structures for native and lipid-depleted ferroxidase-II 
would still exist. 
Another possible explanation of the loss of activity following the 
hydrolysis of phospholipid was explored. The hydrolysis and loss of the 
bound lipids could be accompanied by a loss of copper from ferroxidase-
II. In vivo and in vitro studies have shown that copper plays a 
functional role in the catalytic activity of ferroxidase-II (48). The 
hydrolysis and removal of the bound lipid of ferroxidase-II was 
accompanied by the loss of copper. The hydrolysis of the phospholipids 
could cause a subtle change in the structure of ferroxidase-II which 
would, in turn, reduce the affinity of ferroxidase-II for copper. The 
reduction of the affinity of ferroxidase-II for copper could result 
from the movement of groups in the protein {possibly side-chain amino 
or sulfur groups) so that they are no longer in the proper alignment 
for forming a strong ligand complex with copper. It is also possible 
that the polar groups of the phospholipids (the oxygen of the phosphate 
group, the nitrogen of the choline group) could be directly involved in 
binding of copper to the enzyme. The hydrolysis of phospholipids could 
weaken the ability of the groups to participate in cooperation with the 
groups in the protein in the binding of copper. The exact manner in 
which the lipid, copper, and protein are associated with one another has 
not been ascertained. However, these studies would indicate that the 
association among them is indispensable to the catalytic function of 
ferroxidase-II. 
74 
Attempts to reconstitute the lipid-depleted form of ferroxidase-II 
by the addition of phosphatidylcholine; phosphatidylcholine and cholesterol; 
and phosphatidylcholine, cholesterol, and copper resulted in little 
regeneration of ferroxidase activity. This suggests that any structural 
change and change in affinity for copper occurring during hydrolysis and 
removal of bound lipid are not readily reversible. 
Ceruloplasmin and ferroxidase-II have been found in the sera of all 
animals investigated to date and these proteins are the sole source of 
ferroxidase activity in these animal sera. A detailed comparison of 
some of the chemical properties of these two proteins was made in tabular 
form in the "Literature Review". However, it is interesting to compare 
these proteins from a slightly different point of view. Both proteins 
contain extremely tightly bound copper atoms. In addition, ceruloplasmin 
contains some bound carbohydrate residues and is thus classified as a 
glycoprotein. Cartwright, et aZ. (25) demonstrated from in vivo studies 
that the loss of these carbohydrate residues resulted in a loss in the 
ability of ceruloplasmin to mobilize iron from liver storage cells. In 
contrast, ferroxidase-II contains no bound carbohydrate residues but it 
contains bound lipid components and is thus considered a lipoprotein. 
The studies described in this thesis have demonstrated that the lipid 
components of ferroxidase-II are essential for the maintenance of its 
ferroxidase activity. Cartwright, et aZ. (25) have suggested that 
possibly the carbohydrate residues of ceruloplasmin may in some manner 
promote the specific binding of some of the circulating ceruloplasmin 
to the surface of the liver storage cell. This bound ceruloplasmin 
would be ideally located for promoting the oxidation of any Fe(II) 
passing from the liver storage cell into the blood stream. It is possible 
that the lipid components of ferroxidase-II could promote the specific 
binding of ferroxidase-II to the surface of the liver storage cell. 
This appears particularly feasible because the membrane composing the 
liver cell surface is rich in phospholipids and cholesterol. Thus, 
the liver cell membrane represents a hydrophobic environment which 
could bind the hydrophobic-lipid rich region of ferroxidase-II. 
Verification of this, however, must await further experimentation. 
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In summary, ferroxidase-II represents a very interesting and 
complex enzyme. It not only contains tightly bound copper but also 
tightly bound lipid components and both appear essential for the 
maintenance of the catalytic and physiological function of the enzyme. 
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